American Heart Association Scientific Sessions 2004: Brain and Heart

References

• Miyasaka Y, Barnes ME, Cha SS, Bailey KR, Tsang TSM. Overall and sex-specific trends and prognosis of ischemic stroke following incident atrial fibrillation: data from 2 decades (1980–2000). American Heart Association Scientific Sessions 2004. New Orleans, LA, USA, 7–10th November 2004 (Abstract 2976).
   Google Scholar
• The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N. Engl. J. Med.347, 1825–1833 (2002).
   PubMed Web of Science ®Google Scholar
• Olsson SB and the Executive Steering Committee on behalf of the SPORTIF III Investigators. Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with nonvalvular atrial fibrillation (SPORTIF III): randomized controlled trial. Lancet362, 1691–1698 (2003).
   PubMed Web of Science ®Google Scholar
• Durand DJ, Baumgartner WA, Fleischman B, Conte JV, Vricella LA, Yuh DD. Combined carotid endarterectomy (CEA)/coronary artery bypass (CAB): is it effective in reducing perioperative stroke? American Heart Association Scientific Sessions 2004. New Orleans, LA, USA, 7–10th November 2004 (Abstract 2977).
   Google Scholar
• Mega JL, Cairns R, Cannon CP. Intensive and moderate lipid lowering strategies with statins are associated with a similar risk of cerebrovascular events in patients with acute coronary syndromes. American Heart Association Scientific Sessions 2004. New Orleans, LA, USA, 7–10th November 2004 (Abstract 2978).
   Google Scholar
• Collins R, Armitage J, Parish S, Sleight P, Peto R, Heart Protection Study Collaborative Group. Effects of cholesterol lowering with simvastatin on stroke and other major vascular events in 20,536 people with cerebrovascular disease or other high-risk conditions. Lancet363, 757–767 (2004).
   PubMed Web of Science ®Google Scholar
• Cannon CP, Braunwald E, McCabe CH et al. Pravastatin Or atorVastatin Evaluation and Infection Therapy – Thrombolysis In Myocardial Infarction (PROVE IT–TIMI) 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N. Engl. J. Med.350, 1495–1504 (2004).
   PubMed Web of Science ®Google Scholar
• Ballantyne CM, Hoogeveen RC, Bang H et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for ischemic stroke in middle-aged men and women in the atherosclerosis risk in communities study. American Heart Association Scientific Sessions 2004. New Orleans, LA, USA, 7–10th November 2004 (Abstract 2979).
   Google Scholar
• Varanasi JS, Hinderliter AL, Duch PM, Menon V, Oppenheimer SM, Ohman EM. Elevated homocysteine level is independently associated with progression of aortic arch atheroma. American Heart Association Scientific Sessions 2004. New Orleans, LA, USA, 7–10th November 2004 (Abstract 2980).
   Google Scholar
• Cook DJ, Trenerry MR, Huston J 3rd. Cognitive deficit following cardiac surgery is not a function of perioperative cerebral ischemia. American Heart Association Scientific Sessions 2004. New Orleans, LA, USA, 7–10th November 2004 (Abstract 2981).
   Google Scholar
• Floyd TF, McGarvey M, Ochroch EA et al. Perioperative changes in cerebral blood flow after cardiac surgery: influence of anemia and aging. Ann. Thorac. Surg.76, 2037–2042 (2003).
   PubMed Web of Science ®Google Scholar
• Ranade K, Lakoubova OA, Devlin JJ et al. Identification of genetic risk factors for atherosclerosis and drug response markers using clinical trials of the cholesterol-lowering drug pravastatin. American Heart Association Scientific Sessions 2004. New Orleans, LA, USA, 7–10th November 2004 (Abstract 2982).
   Google Scholar
• Ishikawa J, Kario K, Morinari M. C-2011;reactive protein as a risk factor for multiple silent cerebral infarcts in Japanese hypertensive subjects. American Heart Association Scientific Sessions 2004. New Orleans, LA, USA, 7–10th November 2004 (Abstract 2983).
   Google Scholar
• Kario K, Shimada K, Matsuo T, Hoshide S, Schwartz JE, Pickering TG. Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J. Am. Coll. Cardiol.38, 238–245 (2001).
   PubMed Web of Science ®Google Scholar
• Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension38, 852–857 (2001).
   PubMed Web of Science ®Google Scholar
• Kario K, Pickering TG, Umeda Y et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation107, 1401–1406 (2003).
   PubMed Web of Science ®Google Scholar
• Kario K, Pickering TG. Blood pressure variability in elderly patients. Lancet355, 1645–1646 (2000).
   PubMed Web of Science ®Google Scholar
• Curb D, Abbott RD, Rodriguez BL et al. C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation107, 2016–2020 (2003).
   PubMed Web of Science ®Google Scholar
• Flex A, Gaetani E, Papaleo P et al. Proinflammatory genetic profiles in subjects with history of ischemic stroke. American Heart Association Scientific Sessions 2004. New Orleans, LA, USA, 7–10th November 2004 (Abstract 2984).
   Google Scholar
• Sampson UK, Kenchaiah S, Swedberg K et al. Modifiable risk factors for stroke in high-risk patients following acute myocardial infarction: insights from the VALIANT study. American Heart Association Scientific Sessions 2004. New Orleans, LA, USA, 7–10th November 2004 (Abstract 2985).
   Google Scholar